COVID-19 Hospitalization Not Tied to Rituximab Timing, Dose in Patients With MS
Researchers sought to examine the association between timing and dose of rituximab and hospitalization for COVID-19 in patients with multiple sclerosis in Sweden.
Multiple Sclerosis
Immunosuppressive Therapies and COVID-19 Risk in Children With Neuroimmunologic Disorders
In a retrospective survey, researchers assessed whether children receiving immunosuppressive therapies for neuroimmunologic diseases were disproportionately affected by COVID-19.
Visual Complaints Common Among Patients With Multiple Sclerosis
General practitioners may not discuss vision-related quality of life for people with MS, and may infrequently refer them to appropriate care.
COVID-19 mRNA Vaccines Effective in Patients With MS on Disease-Modifying Drugs
Researchers sought to determine the efficacy of COVID-19 mRNA vaccines and immune-specific response of patients with MS treated with various disease-modifying drugs.
Loss of Balance Trends in Patients With Multiple Sclerosis and Parkinson Disease
Researchers sought to systematically classify loss of balance trends among patients with multiple sclerosis and Parkinson disease.
Multiple Sclerosis and Pregnancy: Outcomes of Early Dimethyl Fumarate Exposure
Using data from a prospective, international registry, researchers assessed whether delayed-release dimethyl fumarate exposure affects pregnancy and infant outcomes among pregnant women with multiple sclerosis.
Rituximab-Induced Hypogammaglobulinemia and Infection Risk in Multiple Sclerosis
In a prospective observational study, researchers investigated the incidence of hypogammaglobulinemia and infections in patients with MS who were treated with rituximab in the MS center of Marseille, France.
Ublituximab Under Review for Relapsing Forms of Multiple Sclerosis
Ublituximab is an investigational glycoengineered monoclonal antibody that targets CD20.
The Effect of Erythropoietin on Visual Outcomes in Optic Neuritis
In a phase 3 trial, researchers assessed the safety and efficacy of erythropoietin in patients with optic neuritis as a clinically isolated syndrome.
Adapted Ketogenic Diet and Neuroprotective Benefits in Multiple Sclerosis
Using single molecule array assay, researchers examined sNfL levels of patients with MS who were either on a common diet or ketogenic diet or fasting.
- Loading...
Loading...
Next post in Multiple Sclerosis
Loading... 
Loading...